Excitingly, ECN-pE(C/A)2 treatment effectively protected the mice against DSS-induced acute IBD, including colon length shortening, body weight loss, colon epithelial tissue damage and increased MPO activity (Fig. 6b–g and Supplementary Fig. 19). The gene discussed is MPO; the disease is inflammatory bowel disease.